4
Changes in Ownership
Adaptive Biotechnologies Corp Filed Acc 0001209191-22-017394
Chief Scientific Officer sold 4,517 shares at $12.01 ($54,249)
- Chief Scientific Officer acquired 247,117 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2022-03-04 | Grant or award | +247,117 | 316,477 | D: show line 1 in the form | ||
| ROBINS HARLAN S Chief Scientific Officer | 2022-03-07 | Sale | −4,517 | $12.01 | $54,249 | 311,960 | D: show line 2 in the form |
| Open-market sales · 4,517 sh · avg $12.01 · $54,249 | |||||||
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| ROBINS HARLAN S Chief Scientific Officer | 2022-03-04 | Grant or award · Stock Option (Right to Buy) | +617,792 | 617,792 | D: show line 3 in the form |
Loading xslF345X03/doc4.xml…